A one-hit model can be applied to the initiation of APL and CML whereas a two-hit model is more suitable to the initiation of AML with RUNX1-RUNX1T1 and other AMLs. This evidence concerns the gene RUNX1T1 and chronic myelogenous leukemia, BCR-ABL1 positive.